RxDoctor Payments Data

Heidi Chappell

Adult Health · Gastonia, NCNPI 1629587167

Payments from drug & device makers

$1,996in general payments, 2019–2025

Across 53 payments — averaging $37.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$467
  • Abbott$324
  • Medtronic$242
  • E.r. Squibb & Sons, L.L.C.$195
  • Heartflow, Inc.$193
  • Boston Scientific$181
  • plus $394 from 5 others

What the payments were for

  • Food & beverage$1,996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,996 in reported general payments places this provider in the 75th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$20,641
Medicare patients
162
Services billed
242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CamzyosMavacamten26$224,507
EliquisApixaban60$57,720
EntrestoSacubitril/Valsartan37$30,885
XareltoRivaroxaban15$11,913
BrilintaTicagrelor11$5,684
Metoprolol Succinate74$922
Atorvastatin Calcium44$466
Potassium Chloride34$414
ClopidogrelClopidogrel Bisulfate48$350
Furosemide96$329
Torsemide16$323
Nitroglycerin19$217
Losartan Potassium22$175
Amiodarone Hcl14$158
Spironolactone29$132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Camzyos$195$224,50726 claims
AstraZenecaBrilinta$14$5,68411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 614 adult health providers in North Carolina.

Other adult health in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →